about
An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors.Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer's diseaseAssociated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproateImaging the accumulation and suppression of tau pathology using multiparametric MRI.Comparison of In Vivo and Ex Vivo MRI for the Detection of Structural Abnormalities in a Mouse Model of Tauopathy.Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?The discovery of a highly selective 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one SIRT2 inhibitor that is neuroprotective in an in vitro Parkinson's disease model.In Vivo Imaging of Tau Pathology Using Magnetic Resonance Imaging Textural Analysis.Tissue magnetic susceptibility mapping as a marker of tau pathology in Alzheimer's disease.Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.Prazosin, an α(1)-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease.Non-invasive imaging of CSF-mediated brain clearance pathways via assessment of perivascular fluid movement with diffusion tensor MRIOptic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementiaStudy the Longitudinal and Cross-Sectional Brain Volume Difference for Disease Progression and Treatment Effect on Mouse Model of Tauopathy Using Automated MRI Structural ParcellationImpaired brain glymphatic flow in experimental hepatic encephalopathyThe histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's diseaseCorrigendum to "Impaired brain glymphatic flow in experimental hepatic encephalopathy" [J Hepatol 69 (2019) 40-49]Imaging of X-Ray-Excited Emissions from Quantum Dots and Biological Tissue in Whole MouseNon-Invasive MRI of Blood-Cerebrospinal Fluid Barrier Function
P50
Q35057159-F328A5DA-1DA6-4D80-9800-AAB44946A1CBQ35978159-A52B4C00-A679-4585-94E0-2C93FED1F153Q36408071-CA093464-2D0B-467A-A27A-2A948796C8F2Q36587423-F17853DA-2F53-4C1F-AD31-055A7274B352Q36663462-25B0C4FF-AA9E-40A4-A0D5-1FBF53E5EDEAQ36663462-76314465-BBDD-43B0-B7EB-50C5D8612E58Q37731923-7708694F-9F0E-433C-8229-ACBDEB35872FQ37731923-FAA32906-C6F5-4681-8277-24D4037DB58BQ38109784-A49FCDEB-571E-451C-A7AD-BCFFD9F7F502Q38940509-A826F628-DE44-4AE4-A3D8-55085F41E250Q47132828-8099389D-20F4-47E1-80DE-8D8FDBC155B0Q47132828-B96487E8-A07A-4813-B266-7B72C313ADF8Q47161099-68492569-2846-4EEB-9791-974BB7FA05E3Q47259835-DFDFEF4A-7118-4CA6-862C-9A46763E94A8Q48337593-12148A4F-B063-4030-97E7-4CE0B0848DA6Q56530686-A6838151-80CB-4FF8-8157-33363A183C46Q60918160-B9D4B749-3255-46C5-ADD6-D365B70041C6Q61810295-B083B53C-9AE9-4801-B18E-FD78C78179CEQ62125857-D6A51042-9525-4A65-A718-F6E676255739Q64859138-0DBD65B0-ED5E-4CE5-9A5D-674F73802620Q90927948-752E0502-0230-428D-ADC5-CFA7990A5AC7Q92024998-98886884-BD3E-42A8-AD86-FA1FED25F84BQ94461646-42D71674-335B-47CF-B48B-B39E380AED0F
P50
description
researcher
@en
հետազոտող
@hy
name
Ian Harrison
@ast
Ian Harrison
@en
Ian Harrison
@es
Ian Harrison
@nl
type
label
Ian Harrison
@ast
Ian Harrison
@en
Ian Harrison
@es
Ian Harrison
@nl
altLabel
Ian F. Harrison
@en
prefLabel
Ian Harrison
@ast
Ian Harrison
@en
Ian Harrison
@es
Ian Harrison
@nl
P106
P1153
55382681000
P2798
P31
P496
0000-0003-1250-4911